Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07049614

Comparative Study of Postoperative Surgical Site Infections in Diabetic and Non-Diabetic Patients

Comparative Study of Postoperative Surgical Site Infections in Diabetic and Non-Diabetic Patients Undergoing General Surgical Procedures

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
132 (actual)
Sponsor
Superior University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This prospective observational study aims to compare the incidence and characteristics of postoperative surgical site infections (SSIs) between diabetic and non-diabetic patients undergoing elective general surgical procedures.

Detailed description

Diabetes mellitus is a well-known risk factor for delayed wound healing and postoperative complications. The study seeks to identify how diabetic status influences SSI rates, types (superficial, deep, organ/space), and associated risk factors such as glycemic control (HbA1c), duration of diabetes, and presence of comorbidities.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTDiabetic PatientsThis group consists of 66 adult diabetic patients (Type 1 or Type 2) undergoing elective general surgical procedures. These patients will be managed as per standard clinical protocols, including preoperative evaluation, glycemic control assessment (via recent HbA1c and blood glucose levels), and administration of prophylactic broad-spectrum antibiotics-typically second-generation cephalosporins and metronidazole. Postoperative follow-up will be conducted on Day 1, Day 7, and Day 14 to monitor for the development of surgical site infections (SSIs), which will be classified by the unit chief as superficial, deep, or organ/space infections.
DIAGNOSTIC_TESTNon-Diabetic PatientsThis group includes 66 adult non-diabetic patients undergoing elective general surgical procedures at DHQ Hospital, Dera Ismail Khan. These participants will serve as the comparison group for evaluating the incidence and characteristics of postoperative surgical site infections (SSIs). All patients will receive standard preoperative assessments and prophylactic antibiotics (second-generation cephalosporins with metronidazole) as per institutional protocols. Postoperative follow-up will be carried out on Day 1, Day 7, and Day 14, and SSIs, if any, will be classified based on CDC criteria into superficial, deep, or organ/space infections

Timeline

Start date
2025-03-17
Primary completion
2025-09-01
Completion
2026-02-28
First posted
2025-07-03
Last updated
2025-07-03

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT07049614. Inclusion in this directory is not an endorsement.